BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16831918)

  • 1. Understanding parathyroid hormone action.
    Partridge NC; Li X; Qin L
    Ann N Y Acad Sci; 2006 Apr; 1068():187-93. PubMed ID: 16831918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
    Kobayashi T
    Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
    Goltzman D
    Arch Biochem Biophys; 2008 May; 473(2):218-24. PubMed ID: 18358824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
    Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
    J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The parathyroid hormones: bone-forming agents for treatment of osteoporosis.
    Whitfield JF; Morley P; Willick GE
    Medscape Womens Health; 2000; 5(5):E5. PubMed ID: 11113778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parathyroid and bone. The mechanism of anabolic function of parathyroid hormone on bone].
    Ogata N; Kawaguchi H
    Clin Calcium; 2007 Dec; 17(12):1843-9. PubMed ID: 18057659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in skeletal anabolic therapies.
    Martin TJ; Quinn JM; Gillespie MT; Ng KW; Karsdal MA; Sims NA
    Ann N Y Acad Sci; 2006 Apr; 1068():458-70. PubMed ID: 16831943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residue "switch" revealed in PTH system.
    Kling J
    Nat Biotechnol; 1996 Nov; 14(11):1545. PubMed ID: 9634818
    [No Abstract]   [Full Text] [Related]  

  • 9. Back to the future: revisiting parathyroid hormone and calcitonin control of bone remodeling.
    de Paula FJ; Rosen CJ
    Horm Metab Res; 2010 May; 42(5):299-306. PubMed ID: 20217631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone stimulation of noncanonical Wnt signaling in bone.
    Bergenstock MK; Partridge NC
    Ann N Y Acad Sci; 2007 Nov; 1116():354-9. PubMed ID: 18083937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathways regulating bone formation: a complex network].
    Thomas T; Martin A
    J Soc Biol; 2008; 202(4):257-64. PubMed ID: 19094924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism.
    Friedl G; Turner RT; Evans GL; Dobnig H
    J Orthop Res; 2007 Nov; 25(11):1454-64. PubMed ID: 17557320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormones and osteoporosis update. Histological aspects on the action of parathyroid hormone (PTH) and PTH-related peptide (PTHrP) on bone and cartilage].
    Amizuka N; Li M; Tamura M; Oda K
    Clin Calcium; 2009 Jul; 19(7):935-43. PubMed ID: 19567988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mechanisms and targets in the treatment of bone fragility.
    Martin TJ; Seeman E
    Clin Sci (Lond); 2007 Jan; 112(2):77-91. PubMed ID: 17155930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stanniocalcin 2 is positively and negatively controlled by 1,25(OH)(2)D(3) and PTH in renal proximal tubular cells.
    Takei Y; Yamamoto H; Masuda M; Sato T; Taketani Y; Takeda E
    J Mol Endocrinol; 2009 Mar; 42(3):261-8. PubMed ID: 19131501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
    Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
    J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some aspects of the anabolic action of parathyroid hormone.
    Martin TJ; Allan EH; Fukumoto S; Moseley JM
    Miner Electrolyte Metab; 1995; 21(1-3):87-90. PubMed ID: 7565470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parathyroid and bone. Effects of parathyroid hormone on bone resorption and formation: differences between intermittent and continuous treatment].
    Kaji H
    Clin Calcium; 2007 Dec; 17(12):1836-42. PubMed ID: 18057658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.
    Wang Y; Qin QH; Kalyanasundaram S
    Mol Cell Biomech; 2009 Jun; 6(2):101-12. PubMed ID: 19496258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.